{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T23:55:30Z","timestamp":1795218930003,"version":"4.10.3"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jahonline.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Adolescent Health"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jadohealth.2016.04.012","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T21:48:09Z","timestamp":1469137689000},"page":"S3-S11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":183,"special_numbering":"S","title":["The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines"],"prefix":"10.1016","volume":"59","author":[{"given":"Stephen I.","family":"Pelton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jadohealth.2016.04.012_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/hv.22302","article-title":"The changing epidemiology of meningococcal disease in North America 1945-2010","volume":"9","author":"Baccarini","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib2","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/cid\/ciu597","article-title":"The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012","volume":"59","author":"Sadarangani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/INF.0000000000000282","article-title":"The clinical features and long-term sequelae of invasive meningococcal disease in children","volume":"33","author":"Stein-Zamir","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 2","key":"10.1016\/j.jadohealth.2016.04.012_bib4","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: Clinical presentation and sequelae","volume":"30","author":"Pace","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: Implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib6","unstructured":"European Centre for Disease Prevention and Control. Surveillance of invasive bacterial diseases in Europe. Available at: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/invasive-bacterial-diseases-surveillance-2011.pdf. Accessed April 13,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(12)70168-8","article-title":"Serogroup a meningococcal conjugate vaccination in Burkina Faso: Analysis of national surveillance data","volume":"12","author":"Novak","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib8","unstructured":"Australian Government Department of Health. Meningococcal - Australian meningococcal surveillance programme annual reports. Available at: http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-pubs-annlrpt-menganrep.htm. Accessed August 18,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib9","unstructured":"Centers for Disease Control and Prevention. Active bacterial core surveillance (ABCs) surveillance reports. Available at: http:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed August 18,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3201\/eid1904.111799","article-title":"Description and nomenclature of Neisseria meningitidis capsule locus","volume":"19","author":"Harrison","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-346-2_1","article-title":"Neisseria meningitidis: Biology, microbiology, and epidemiology","volume":"799","author":"Rouphael","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-7954-11-17","article-title":"Global epidemiology of invasive meningococcal disease","volume":"11","author":"Jafri","year":"2013","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(98)00279-7","article-title":"Uncloaking the meningococcus: Dynamics of carriage and disease","volume":"353","author":"Stephens","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib14","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1574-6976.2006.00056.x","article-title":"Multilocus sequence typing for global surveillance of meningococcal disease","volume":"31","author":"Brehony","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib16","unstructured":"Scottish Intercollegiate Guidelines Network. Management of invasive meningococcal disease in children and young people. Available at: http:\/\/www.sign.ac.uk\/pdf\/sign102.pdf. Accessed October 1,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib17","first-page":"1","article-title":"Prevention and control of meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1542\/peds.2014-1383","article-title":"Updated recommendations on the use of meningococcal vaccines","volume":"134","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib19","first-page":"608","article-title":"Use of serogroup B meningococcal vaccines in persons aged >\/=10 years at increased risk for serogroup B meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices, 2015","volume":"64","author":"Folaranmi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib20","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/428590","article-title":"Genetic analysis of meningococci carried by children and young adults","volume":"191","author":"Claus","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib21","first-page":"43","article-title":"Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy","volume":"71","author":"Jeppesen","year":"2015","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib22","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/infdis\/jiv211","article-title":"The diversity of meningococcal carriage across the African meningitis belt and the impact of vaccination with a group A meningococcal conjugate vaccine","volume":"212","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib23","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1084\/jem.20050112","article-title":"A\u00a0chromosomally integrated bacteriophage in invasive meningococci","volume":"201","author":"Bille","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib24","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1099\/mic.0.29261-0","article-title":"Comparative genomics of Neisseria meningitidis: Core genome, islands of horizontal transfer and pathogen-specific genes","volume":"152","author":"Dunning Hotopp","year":"2006","journal-title":"Microbiology"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2249.2011.04525.x","article-title":"Complete deficiency of the sixth complement component (C6Q0), susceptibility to Neisseria meningitidis infections and analysis of the frequencies of C6Q0 gene defects in South Africans","volume":"167","author":"Orren","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1471-2334-10-175","article-title":"The elusive meningococcal meningitis serogroup: A systematic review of serogroup B epidemiology","volume":"10","author":"Racloz","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1471-2334-12-202","article-title":"Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010","volume":"12","author":"Dang","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib28","doi-asserted-by":"crossref","first-page":"e50659","DOI":"10.1371\/journal.pone.0050659","article-title":"The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: Potential implications of emergence of new strains","volume":"7","author":"Gilca","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib29","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1542\/peds.2014-2035","article-title":"Epidemiology of infant meningococcal disease in the United States, 2006-2012","volume":"135","author":"MacNeil","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib30","doi-asserted-by":"crossref","first-page":"e71943","DOI":"10.1371\/journal.pone.0071943","article-title":"A\u00a0decade of invasive meningococcal disease surveillance in Poland","volume":"8","author":"Skoczynska","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1473-3099(14)70805-9","article-title":"Epidemiology of bacterial meningitis in the USA from 1997 to 2010: A population-based observational study","volume":"14","author":"Castelblanco","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib32","first-page":"121","article-title":"Reducing mortality from emerging diseases","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"issue":"Suppl 1","key":"10.1016\/j.jadohealth.2016.04.012_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/0037-8682-0116-2014","article-title":"Epidemiology of infectious meningitis in the State of Amazonas, Brazil","volume":"48","author":"Saraiva","year":"2015","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib34","first-page":"1","article-title":"Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib35","first-page":"72","article-title":"Updated recommendations for use of meningococcal conjugate vaccines \u2013 Advisory Committee on Immunization Practices (ACIP), 2010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib36","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.15585\/mmwr.mm6441a3","article-title":"Use of serogroup B meningococcal vaccines in adolescents and young adults: Recommendations of the Advisory Committee on Immunization Practices, 2015","volume":"64","author":"MacNeil","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm6253a1","article-title":"Summary of notifiable infectious diseases and conditions - United States, 2013","volume":"62","author":"Adams","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib38","unstructured":"Centers for Disease Control and Prevention. National vital statistics system. Mortality data. Available at: http:\/\/www.cdc.gov\/nchs\/deaths.htm. Accessed February 16,\u00a02016."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib39","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/infdis\/jiu842","article-title":"Changes in the population structure of invasive Neisseria meningitidis in the United States after quadrivalent meningococcal conjugate vaccine licensure","volume":"211","author":"Wang","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib40","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3201\/eid2108.141837","article-title":"Community-based outbreak of Neisseria meningitidis serogroup C infection in men who have sex with men, New York city, New York, USA, 2010-2013","volume":"21","author":"Kratz","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib41","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.28.20523","article-title":"A\u00a0cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013","volume":"18","author":"Marcus","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib42","doi-asserted-by":"crossref","first-page":"e107486","DOI":"10.1371\/journal.pone.0107486","article-title":"The association of meningococcal disease with influenza in the United States, 1989-2009","volume":"9","author":"Jacobs","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1473-3099(14)70806-0","article-title":"Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: An analysis of national surveillance data","volume":"14","author":"Bijlsma","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib44","first-page":"48","article-title":"Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine","volume":"66","author":"Hellenbrand","year":"2013","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib45","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: Effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib46","unstructured":"European Centre for Disease Prevention and Control. Surveillance of invasive bacterial diseases in Europe (2007). Available at: http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/101011_SUR_Surveillance_of_invasive_bacterial_diseases_in_Europe_2007.pdf. Accessed October 1,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib47","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.42.20940","article-title":"Surveillance of invasive Neisseria meningitidis with a serogroup Y update, Sweden 2010 to 2012","volume":"19","author":"Toros","year":"2014","journal-title":"Euro Surveill"},{"issue":"Suppl 2","key":"10.1016\/j.jadohealth.2016.04.012_bib48","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.vaccine.2009.04.067","article-title":"Meningococcal C conjugate vaccine: The experience in England and Wales","volume":"27","author":"Campbell","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2334-12-35","article-title":"Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? Experience from the Netherlands","volume":"12","author":"Kaaijk","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1574-6976.2006.00053.x","article-title":"Vaccination against meningococcal disease in Europe: Review and recommendations for the use of conjugate vaccines","volume":"31","author":"Trotter","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib51","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1080\/21645515.2015.1051276","article-title":"Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013","volume":"11","author":"Broker","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3201\/eid1801.110901","article-title":"Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009","volume":"18","author":"Ladhani","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/cid\/ciu881","article-title":"Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales","volume":"60","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib54","unstructured":"Public Health England (PHE). Meningococcal group W (MenW) immunisation advised for 14 to 18 year-olds. Available at: https:\/\/www.gov.uk\/government\/news\/meningococcal-group-w-menw-immunisation-advised-for-14-to-18-year-olds. Accessed September 30,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S0950268812001689","article-title":"The epidemiology of meningococcal disease in Latin America 1945-2010: An unpredictable and changing landscape","volume":"141","author":"Safadi","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib56","doi-asserted-by":"crossref","first-page":"e44102","DOI":"10.1371\/journal.pone.0044102","article-title":"Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010","volume":"7","author":"Ibarz-Pavon","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bjid.2013.11.012","article-title":"Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil","volume":"18","author":"Tauil Mde","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib58","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1017\/S0950268814001149","article-title":"Serogroup W meningococcal disease: Global spread and current affect on the Southern Cone in Latin America","volume":"142","author":"Abad","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3201\/eid2102.140746","article-title":"Neisseria meningitidis ST-11 clonal complex, Chile 2012","volume":"21","author":"Araya","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib60","doi-asserted-by":"crossref","first-page":"e66006","DOI":"10.1371\/journal.pone.0066006","article-title":"Molecular characterization of invasive Neisseria meningitidis strains isolated in Chile during 2010-2011","volume":"8","author":"Barra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib61","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1016\/j.vaccine.2012.06.044","article-title":"Impact of vaccination during an\u00a0epidemic of serogroup C meningococcal disease in Salvador, Brazil","volume":"30","author":"Cardoso","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib62","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3201\/eid2005.130948","article-title":"Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010","volume":"20","author":"Safadi","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib63","doi-asserted-by":"crossref","first-page":"e0123734","DOI":"10.1371\/journal.pone.0123734","article-title":"Effectiveness of meningococcal C conjugate vaccine in Salvador, Brazil: A case-control study","volume":"10","author":"Cardoso","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1016\/j.jadohealth.2016.04.012_bib64","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib65","unstructured":"Mayer L. Meningococcal disease: the African meningitis belt. Available at: http:\/\/compgenomics2010.biology.gatech.edu\/wiki\/images\/6\/6d\/Meningococcal_disease_in_africa_2010_xLWM.pdf. Accessed October 1,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib66","first-page":"313","article-title":"Enhanced surveillance of epidemic meningococcal meningitis in Africa: A three-year experience","volume":"80","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib67","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3201\/eid0705.010513","article-title":"Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa","volume":"7","author":"Nicolas","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib68","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib69","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4161\/hv.19619","article-title":"Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM)","volume":"8","author":"Frasch","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 2","key":"10.1016\/j.jadohealth.2016.04.012_bib70","doi-asserted-by":"crossref","first-page":"B40","DOI":"10.1016\/j.vaccine.2011.12.073","article-title":"Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience","volume":"30","author":"Djingarey","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib71","first-page":"206","article-title":"Meningococcal disease control in countries of the African meningitis belt, 2013","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib72","first-page":"129","article-title":"Meningococcal disease in countries of the African meningitis belt, 2012-emerging needs and future perspectives","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib73","first-page":"123","article-title":"Meningococcal disease control in countries of the African meningitis belt, 2014","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib74","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3201\/eid2003.131407","article-title":"Neisseria meningitidis serogroup W, Burkina Faso, 2012","volume":"20","author":"MacNeil","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib75","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study [corrected]","volume":"383","author":"Daugla","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib76","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1186\/1471-2334-13-576","article-title":"Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination","volume":"13","author":"Collard","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib77","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.vaccine.2013.04.036","article-title":"Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine","volume":"31","author":"Xie","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib78","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1471-2334-12-205","article-title":"Emergence of serogroup C meningococcal disease associated with a high mortality rate in Hefei, China","volume":"12","author":"Xu","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1099\/jmm.0.45541-0","article-title":"Characterization of Neisseria meningitidis isolates collected from 1974 to 2003 in Japan by multilocus sequence typing","volume":"53","author":"Takahashi","year":"2004","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7883\/yoken.JJID.2014.127","article-title":"Meningococcal meningitis with meningococcemia: A rare sporadic case in an elderly patient with no history of contact with infected individuals","volume":"68","author":"Gomi","year":"2015","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib81","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7883\/yoken.JJID.2008.434","article-title":"Serological and genetic characterization of meningococcal isolates in Korea","volume":"61","author":"Bae","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib82","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1471-2334-12-310","article-title":"An expanded age range for meningococcal meningitis: Molecular diagnostic evidence from population-based surveillance in Asia","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3947\/ic.2013.45.1.113","article-title":"Commencement of the meningococcal vaccination for the republic of Korea army","volume":"45","author":"Lee","year":"2013","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/2047773214Y.0000000126","article-title":"Global practices of meningococcal vaccine use and impact on invasive disease","volume":"108","author":"Ali","year":"2014","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib85","first-page":"196","article-title":"Annual report of the Australian Meningococcal Surveillance Programme, 2002","volume":"27","year":"2003","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib86","first-page":"E301","article-title":"Australian Meningococcal Surveillance Programme annual report, 2013","volume":"38","author":"Lahra","year":"2014","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib87","unstructured":"Lopez L, Sherwood J. The epidemiology of meningococcal disease in New Zealand in 2013. Institute of Enviornmental Science and Research (ESR). Available at: https:\/\/surv.esr.cri.nz\/PDF_surveillance\/MeningococcalDisease\/2013\/2013AnnualRpt.pdf. Accessed October 1,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib88","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.inf.0000258697.05341.2c","article-title":"New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months","volume":"26","author":"Wong","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib89","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1016\/j.vaccine.2011.06.120","article-title":"Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand","volume":"29","author":"Arnold","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib90","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1093\/cid\/civ028","article-title":"Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: A prospective cohort study","volume":"60","author":"Sadarangani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib91","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/cid\/civ506","article-title":"Disease burden of invasive meningococcal disease in the Netherlands between June 1999 and June 2011: A subjective role for serogroup and clonal complex","volume":"61","author":"Stoof","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib92","unstructured":"MacNeil J. Considerations for use of serogroup B meningococcal (MenB) vaccines in adolescents. Available at: http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2015-06\/mening-03-macneil.pdf. Accessed October 6,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib93","unstructured":"Centers for Disease Control and Prevention. Active bacterial core surveillance (ABCs). Available at: http:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed October 6,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib94","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: A\u00a0systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib95","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1016\/j.vaccine.2014.08.015","article-title":"Meningococcal carriage prevalence in university students, 1824 years of age in Santiago, Chile","volume":"32","author":"Rodriguez","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib96","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/infdis\/jiu679","article-title":"Meningococcal carriage among Georgia and Maryland high school students","volume":"211","author":"Harrison","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib97","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/341067","article-title":"Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease","volume":"186","author":"Kellerman","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib98","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3201\/eid1709.101762","article-title":"Carriage of meningococci by university students, United Kingdom","volume":"17","author":"Ala'aldeen","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib99","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/bmj.320.7238.846","article-title":"Changing carriage rate of Neisseria meningitidis among university students during the first week of term: Cross sectional study","volume":"320","author":"Neal","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CVI.00314-12","article-title":"Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine","volume":"20","author":"Ceyhan","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib101","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1365-3156.2007.01929.x","article-title":"Systematic review: Impact of meningococcal vaccination on pharyngeal carriage of meningococci","volume":"12","author":"Dellicour","year":"2007","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib102","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib103","series-title":"2016 Yellow book travelers' health","year":"2016"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib104","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/cid\/cit243","article-title":"Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States","volume":"57","author":"Mandal","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib105","article-title":"A\u00a0prolonged outbreak of invasive meningococcal disease in an extended Irish Traveller family across three Health Service Executive (HSE) areas in Ireland, 2010 to 2013","volume":"20","author":"O'Connor","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib106","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.44.20949","article-title":"Four-month outbreak of invasive meningococcal disease caused by a rare serogroup B strain, identified through the use of molecular PorA subtyping, England, 2013","volume":"19","author":"Chatt","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib107","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1542\/peds.2014-4015","article-title":"First use of a serogroup B meningococcal vaccine in the US in response to a university outbreak","volume":"135","author":"McNamara","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib108","unstructured":"Patel M. Use of serogroup B meningococcal vaccine during outbreaks on college campuses. Available at: http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/min-archiv\/min-2014-02.pdf. Accessed October 1,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib109","unstructured":"University of Oregon. Meningococcemia diagnosed in another UO student; vaccination efforts continue. Available at: http:\/\/around.uoregon.edu\/content\/meningococcemia-diagnosed-another-uo-student-vaccination-efforts-continue. Accessed October 1,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib110","first-page":"606","article-title":"Serogroup B meningococcal disease outbreak and carriage evaluation at a college - Rhode Island, 2015","volume":"64","author":"Soeters","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib111","unstructured":"Oregon Health Authority. 2015 meningococcal update. Available at: https:\/\/public.health.oregon.gov\/DiseasesConditions\/DiseasesAZ\/MeningococcalDisease\/Pages\/Meningococcal-Update.aspx. Accessed June 9,\u00a02015."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib112","unstructured":"Harris S, Donald R, Hawkins JC, et\u00a0al. Bivalent rLP2086 elicits antibodies in individuals that provide broad coverage against MnB strains expressing prevalent and outbreak-associated fHBP variants. Presented at: International Pathogenic Neisseria Conference (IPNC); October 12-17, 2014; Asheville, NC."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib113","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1586\/14760584.2015.1004317","article-title":"Outbreaks of meningococcal B infection and the 4CMenB vaccine: Historical and future perspectives","volume":"14","author":"Whelan","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib114","series-title":"Invasive meningococcal disease among men who have sex with men","year":"2013"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib115","series-title":"Outbreak of invasive meningococcal disease in the EU associated with a mass gathering event, the 23rd World Scout Jamboree, in Japan","year":"2015"},{"key":"10.1016\/j.jadohealth.2016.04.012_bib116","unstructured":"World Health Organization Regional Office for Africa. Cerebrospinal meningococcal disease outbreak in Niger (Update: 8 July 2015). Available at: http:\/\/www.afro.who.int\/en\/clusters-a-programmes\/dpc\/epidemic-a-pandemic-alert-and-response\/outbreak-news\/4693-cerebrospinal-meningococcal-disease-outbreak-in-niger-update-8-july-2015.html. Accessed February 16,\u00a02016."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib117","unstructured":"World Heath Organization. Global alert and response (GAR). Meningococcal disease - Nigeria. Available at: http:\/\/who.int\/csr\/don\/13-march-2015-nigeria\/en\/. Accessed February 16,\u00a02016."},{"key":"10.1016\/j.jadohealth.2016.04.012_bib118","unstructured":"England PH. MenB vaccination: introduction from September 2015. Available at: https:\/\/www.gov.uk\/government\/publications\/menb-vaccination-introduction-from-1-september-2015. Accessed February 16,\u00a02016."}],"container-title":["Journal of Adolescent Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054139X16300404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054139X16300404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T10:49:02Z","timestamp":1706352542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054139X16300404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1054139X16300404"],"URL":"https:\/\/doi.org\/10.1016\/j.jadohealth.2016.04.012","relation":{},"ISSN":["1054-139X"],"issn-type":[{"value":"1054-139X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Adolescent Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jadohealth.2016.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Society for Adolescent Health and Medicine. All rights reserved.","name":"copyright","label":"Copyright"}]}}